Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Oper Dent ; 45(2): 123-133, 2020.
Article in English | MEDLINE | ID: mdl-31693438

ABSTRACT

The objective of this study was to evaluate the 24-month clinical performance of three different bulk-fill restorative resin materials in class II restorations. Forty patients with at least three approximal lesions in premolar and molar teeth participated in the study. A total of 120 class II cavities were restored using Tetric EvoCeram Bulk Fill (n=40), SureFil SDR flow + Ceram.X mono (n=40), and everX Posterior + G-aenial Posterior (n=40) with their respective adhesives according to the manufacturers' instructions. All restorations were placed by one operator. The restorations were evaluated at baseline and at six, 12, 18, and 24 months using modified US Public Health Service criteria by one examiner. The restoration groups for each category were compared using the Pearson chi-square test, while the Cochran Q-test was used to compare the changes across different time points within each restorative material (p<0.05). At the end of 24 months, 94 restorations were evaluated in 33 patients, with a recall rate of 82.5%. There were no statistically significant differences between the groups in terms of retention (p>0.05). At the 24-month recall, two restorations from the SureFil SDR flow + Ceram.X mono group and four from the everX Posterior + G-aenial Posterior group showed slight marginal discoloration and were rated as bravo. No marginal discoloration was observed in any of the Tetric EvoCeram Bulk Fill restorations. Six restorations from the Tetric EvoCeram Bulk Fill group, six from the SureFil SDR flow + Ceram.X mono group, and 12 from the everX Posterior + G-aenial Posterior group received bravo scores in terms of marginal adaptation. No difference was found among the three groups for any of the evaluation criteria tested (p>0.05). There were statistically significant differences between the baseline and 24-month recall in the everX Posterior + G-aenial Posterior group in terms of marginal discoloration (p<0.05). For marginal adaptation, a significant difference was observed between baseline and 24 months for all the restorative resins (p<0.05). All the restorative resins tested performed similarly and showed acceptable clinical performance during the 24-month evaluation.


Subject(s)
Dental Caries , Dental Restoration, Permanent , Composite Resins , Dental Marginal Adaptation , Dental Materials , Humans , Molar
2.
Eur Rev Med Pharmacol Sci ; 19(18): 3360-6, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26439029

ABSTRACT

OBJECTIVE: Several factors are known to affect prognosis of acute leukemia such as age, high leukocyte count, cytogenetic abnormality, performance status and recurrent leukemia. We aimed to investigate the association between cell surface markers and prognostic determinants such as recurrence at 6 and 12 months and survival at 6, 12 and 18 months in acute leukemia patients. PATIENTS AND METHODS: A total of 142 patients, 101 with acute myeloid leukemia (AML) and 41 with B-cell acute lymphoblastic leukemia (B-ALL) were included. The effects of surface markers on survival and recurrence rates were evaluated retrospectively. RESULTS: In AML patients, CD5+ and CD34+ immunophenotypes and in ALL patients cCD22+, CD34+ and CD49f + CD19+ immunophenotypes were positive prognostic indicators. In AML patients CD7 expression, and in ALL patients CD5+, CD7+ and CD117+ immunophenotypes and >90% CD45 expression were negative prognostic indicators. CONCLUSIONS: This study demonstrates that flow cytometry, a common diagnostic tool in acute leukemia, may also have prognostic value in acute leukemia in the future.


Subject(s)
Flow Cytometry/methods , Immunophenotyping/methods , Leukemia, Myeloid, Acute/genetics , Female , Humans , Leukemia, Myeloid, Acute/mortality , Male , Middle Aged , Prognosis
3.
Eur Rev Med Pharmacol Sci ; 19(17): 3142-5, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26400514

ABSTRACT

OBJECTIVE: The aim of this study is to evaluate the iron absorption status by using the oral iron absorption test (OIAT) in older patients with iron deficiency anemia (IDA) in comparison with younger patients. PATIENTS AND METHODS: This is a cross-sectional study including 100 patients with iron deficiency anemia. Patients were divided in two groups; group 1 who is 65 and older and group 2 who is younger than 65. OIAT in which a fasting serum iron level is compared with a second serum iron level obtained three hours following oral ingestion of iron sulfate was performed. An increase in serum iron of at least 100 mcg/dL indicates that oral iron absorption is adequate. The Independent-Samples t-test was used to show the statistical difference between the means of two groups. RESULTS: There were 100 patients in the study; 69 of them have completed the study. The means of the oral iron absorption test results of the groups was compared with an independent t-test, which showed that the mean of group 1 was lower than group 2 and this was statistically significant (p = 0.001). The mean of OIAT results was 86.1 and 163.5 in group 1 and 2 respectively. CONCLUSIONS: In our knowledge, the present study is among the first that shows the status of iron absorption objectively by using OIAT in older patients. Our study shows iron absorption is decreased in older patients with IDA in comparison with younger patients. In the light of this finding; OIAT should be offered before initiating treatment in older patients when IDA is diagnosed and intravenous iron treatment should be considered more on the base of results.


Subject(s)
Anemia, Iron-Deficiency/blood , Iron/blood , Aged , Cross-Sectional Studies , Female , Humans , Male
4.
J Endocrinol Invest ; 38(9): 971-5, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25827711

ABSTRACT

PURPOSE: The evidence regarding association between thyroid disorders and benign and malignant breast diseases is increasing. The studies exploring the relationship between thyroid and breast diseases usually have focused on thyroid autoimmunity and functions in patients with breast pathologies. In this study, we aimed to reveal the frequency of benign breast conditions in patients with nodular thyroid disease (NTD) and Hashimoto's thyroiditis (HT). METHODS: Seventy-one women with NTD, ninety-five women with HT and seventy-two healthy people as a control group were included in the study. Serum thyroid-stimulating hormone, free triiodothyronine, free thyroxine, and thyroid peroxidase autoantibody levels were measured, and thyroid and breast ultrasonography were performed by a single operator in order to determine thyroid and breast pathology. RESULTS: Benign breast diseases were detected in 54.9% of patients with NTD, in 47.4% of those with HT, and 29.2% of control group in the study (p < 0.01 for nodular and Hashimoto groups versus control group). Simple cyst was found to be the most frequent pathology among benign breast diseases; fibrocystic changes, mixed lesions, benign solid mass, ductal ectasia, and complex cyst followed it. No significant relation was found regarding thyroid function and autoimmunity in patients diagnosed with benign breast disease (p > 0.05). CONCLUSIONS: The results of our study support the association between benign breast diseases and thyroid diseases. An important implication of this finding may be demonstration of the necessity of scanning for potential breast pathology in women with nodular or autoimmune thyroid disease in clinical practice.


Subject(s)
Breast Diseases/epidemiology , Goiter, Nodular/epidemiology , Hashimoto Disease/epidemiology , Adult , Autoantibodies/blood , Breast Diseases/blood , Breast Diseases/diagnostic imaging , Case-Control Studies , Comorbidity , Female , Goiter, Nodular/blood , Hashimoto Disease/blood , Humans , Middle Aged , Prevalence , Prospective Studies , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood , Ultrasonography , Young Adult
5.
Eur Rev Med Pharmacol Sci ; 19(24): 4835-40, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26744875

ABSTRACT

OBJECTIVE: Iron deficiency anemia (IDA) is the most common form of anemia. Impaired intake absorption and blood loss are the main factors in the etiology. Impaired absorption can be caused by a decrease in trace elements such as copper and zinc, which are found in the structure of enzymes that coordinate iron metabolism or act as a catalyst for them, and the existence of Helicobacter pylori (H. pylori), which inhibits iron absorption in the stomach. Serum levels of zinc, copper, and H. pylori antibodies were measured in IDA cases, and correlations with IDA were evaluated. PATIENTS AND METHODS: The study group was composed of 115 IDA cases who were followed at hematology outpatient clinics, and the control group was composed of 92 gender- and age-matched healthy individuals. Patients were diagnosed with iron deficiency anemia according to hemoglobin, serum ferritin, and iron levels and total iron-binding capacity. Serum zinc, copper, H. pylori immunoglobulin A (HpIgA) and immunoglobulin G (HpIgG), vitamin B12, and folic acid levels were examined in the blood specimens collected. RESULTS: No statistically significant difference in zinc and copper serum levels between the study and control groups was observed (p > 0.05 for both groups). Although no difference was observed between the HpIgG levels of the two groups, patients with IDA had a statistically significant increase in HpIgA levels (p < 0.05). Pearson's correlation analysis showed that the zinc levels of the IDA group did not have a correlation with any parameters (p < 0.05 for all). Copper levels had a positive correlation with only the HpIgA level in the IDA group (r = 0.222, p = 0.017). CONCLUSIONS: Trace elements and H. pylori infection did not have a correlation with IDA. Elevated levels of HpIgA and positive correlation of HpIgA with copper levels were observed. The literature review clearly suggests that several points require further explanation, and extensive research with larger samples is required.


Subject(s)
Anemia, Iron-Deficiency/microbiology , Helicobacter pylori/immunology , Adult , Anemia, Iron-Deficiency/blood , Antibodies, Bacterial/blood , Case-Control Studies , Copper/blood , Cross-Sectional Studies , Female , Humans , Immunoglobulin A/blood , Immunoglobulin G/blood , Male , Zinc/blood
6.
Cytokine ; 64(1): 413-21, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23727325

ABSTRACT

INTRODUCTION: Ovarian Cancer is the leading cause of death from gynecological malignancy. The poor prognosis is mainly due to presentation at a late stage and poor response to therapy. Much research is needed to identify diagnostic and prognostic biomarkers as well as therapeutic targets for ovarian cancer. Interleukin-8 is expressed by many tumour types and is known to have mitogenic, motogenic and angiogenic effects on tumour cells. AIMS: The aim of this study was to investigate the expression of IL-8 and IL-8 receptors (IL-8RA and IL-8RB) in different histological subtypes of ovarian tumours, as potential prognostic biomarkers in ovarian tumours. MATERIALS AND METHODS: Immunohitochemistry was used to study the expression of IL-8 and IL-8 receptors in 115 ovarian tumours including 21 benign tumours, 25 borderline tumours and 69 carcinomas of serous, clear cell, endometrioid and mucinous types. The correlation of expression profile, tumour type, stage, and progression free survival and overall survival was statistically analysed. RESULTS: IL-8 and IL-8 receptors were expressed in all types of tumours with variable intensity and subcellular distribution. There was a statistically significant correlation between levels of expression and tumour stage and tumour type, being mostly significant in serous tumours. No correlation with patient progression free survival or overall survival was found. CONCLUSION: This is the first study investigating the expression of IL-8 and IL-8 receptors using immunohistochemistry in different types of ovarian tumours, including benign and borderline tumours. IL-8 and IL-8RA are potential prognostic biomarkers and therapeutic targets in ovarian cancer, particularly in ovarian serous carcinoma.


Subject(s)
Interleukin-8/metabolism , Neoplasms, Glandular and Epithelial/metabolism , Ovarian Neoplasms/metabolism , Receptors, Interleukin-8/metabolism , Adenocarcinoma, Clear Cell/metabolism , Adenocarcinoma, Mucinous/metabolism , Biomarkers, Tumor/metabolism , Carcinoma, Endometrioid/metabolism , Carcinoma, Ovarian Epithelial , Cystadenocarcinoma, Serous/metabolism , Disease-Free Survival , Female , Humans , Interleukin-8/biosynthesis , Neoplasm Staging , Prognosis , Receptors, Interleukin-8/biosynthesis , Survival
7.
Clin Ter ; 164(6): 495-7, 2013.
Article in English | MEDLINE | ID: mdl-24424212

ABSTRACT

OBJECTIVE: In this study, we aimed to investigate the iron absorption defects using the oral iron absorption test (OIAT) in patients with iron deficiency anemia (IDA). MATERIALS AND METHODS: Forty-six patients with IDA which nonresponder to oral iron treatment were included in the study. OIAT was started at 8 a.m. after an overnight fast; 52.8 mg of elemental iron were given orally as 160 mg of iron sulfate. Iron levels of all participants were analyzed at baseline and at the 3rd hour of the study. RESULTS: Compared to baseline; serum iron levels whose serum iron levels exceed 91 mcg/ dl in 40(%87) patients. Further investigations in 6 patients revealed that 4 patients had chronic atrophic gastritis with helicobacter pylori infection; while the remaining 2 patients did not have any prominent. CONCLUSIONS: This study demonstrated that OIAT is a good index for the evaluation of absorption defects and can be a screening clinical test of IDA.


Subject(s)
Anemia, Iron-Deficiency/diagnosis , Ferrous Compounds/therapeutic use , Iron/therapeutic use , Administration, Oral , Adult , Anemia, Iron-Deficiency/drug therapy , Cohort Studies , Female , Gastritis, Atrophic/complications , Gastritis, Atrophic/diagnosis , Helicobacter Infections/complications , Helicobacter pylori/isolation & purification , Humans , Male , Middle Aged , Prospective Studies
8.
Clin Ter ; 164(6): e509-10, 2013.
Article in English | MEDLINE | ID: mdl-24424232

ABSTRACT

Liver involvement in mutiple myeloma (MM) is not commonly encountered. In this report, we describe a patient who was diagnosed with IgG kappa type MM. A liver biopsy revealed monoclonal plasma cell infiltration. Hepatomegaly was the sole finding in physical examination and the liver function tests were not disturbed.


Subject(s)
Liver/pathology , Multiple Myeloma/diagnosis , Plasma Cells/pathology , Biopsy , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...